Articles

The TGA has issued two infringement notices totalling $26,640 to a Sydney-based company for alleged unlawful advertising of a TENS device.

The TGA has issued an infringement notice for $2,664 to an individual for a NSW based herbal medicine practitioner for an alleged breach of the Advertising Code.

The TGA has granted provisional approval to AstraZeneca Pty Ltd for its tixagevimab and cilgavimab (EVUSHELD) for the prevention of COVID-19 in people who are at risk of infection but have not been exposed to the virus, known as pre-exposure prevention of COVID-19.

The TGA has issued two infringement notices totalling $5,328 to a Melbourne-based individual for alleged unlawful importation of nicotine vaping products.

The TGA has provisionally approved the Moderna CoVID-19 vaccine, SPIKEVAX, for use in individuals 6 years and older.

The TGA has issued an infringement notice of $13,320 to Victorian-based company TCF Trading Co Pty Ltd for alleged unlawful importation of COVID-19 rapid antigen tests.

JMIT Distributors Pty Ltd fined $79,920 for alleged advertising breaches of nicotine vaping products under the Therapeutic Goods Act 1989

NSW executive officer fined $10,656 for alleged advertising breaches of the Therapeutic Goods Act 1989 involving nicotine vaping products

The TGA has provisionally approved the AstraZeneca COVID-19 vaccine, Vaxzevria, for use as a booster in individuals aged 18 years and over.

The TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 16 and 17 years old.

No special exemptions to import or supply unapproved RATs

The TGA has granted provisional approval to two oral COVID-19 treatments.

On 19 January 2022 the TGA granted provisional approval to Biocelect Pty Ltd (on behalf of Novavax Inc) in relation to the COVID-19 vaccine, NVX-CoV2373, for individuals aged 18 years and over.

The TGA determined that the two dose course of the Gamaleya Institute vaccine (Sputnik V, Russian Federation) would be 'recognised' for the purpose of establishing a traveller's vaccination status.

The TGA has issued an infringement notice, totalling $26,640, to Ezy Company Pty Ltd for alleged unlawful importation of COVID-19 rapid antigen tests and nicotine vaping products in breach of the Therapeutic Goods Act 1989.

On 4 January 2022 the TGA granted a further provisional determination to AstraZeneca Pty Ltd in relation to the COVID-19 treatment tixagevimab and cilgavimab (EVUSHELD).

The TGA has issued three infringement notices, totalling $7,992, to an individual from South Australia for allegedly advertising medicinal cannabis in breach of the Therapeutic Goods Act 1989.

The TGA has issued three infringement notices totalling $39,960 for alleged unlawful advertising of medicinal cannabis in breach of the Therapeutic Goods Act 1989.

TGA has tested a number of imported products labelled as ivermectin and found that they are counterfeit

The TGA has provisionally approved a booster dose of the Moderna COVID-19 vaccine, SPIKEVAX, for individuals 18 years and older.

Dangerous and prohibited ingredients were found in two out of every three nicotine vaping products tested by the TGA, following a joint operation conducted by ACT Health and the TGA in response to community tip-offs.

New trial (beta) tool to search the Australian Register of Therapeutic Goods (ARTG) available.

TGA grants provisional approval to Celltrion Healthcare Australia Pty Ltd for COVID-19 treatment, regdanvimab (REGKIRONA)

The TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use in individuals 5 years and older.

A new Therapeutic Goods Advertising Code has been made commencing 1 January 2022, with transition period